Dr. Niswander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300
Education & Training
University of Rochester School of Medicine and DentistryClass of 2016
Certifications & Licensure
NY State Medical License 2024 - 2026
PA State Medical License 2019 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic le...Tommaso Balestra, Lisa M Niswander, Asen Bagashev, Joseph P Loftus, Savannah L Ross
Leukemia. 2024-12-16 - 9 citationsClinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax.Lisa M Niswander, Perry Chung, Caroline Diorio, Sarah K Tasian
Haematologica. 2023-11-01 - 18 citationsPotent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against- mutant acute myeloid leukemia and-rearranged acute lymphoblastic l...Lisa M Niswander, Zachary T Graff, Christopher D Chien, John A Chukinas, Christina A Meadows
Haematologica. 2023-02-01
Press Mentions
Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-cell Therapy in Two Pediatric LeukemiasDecember 8th, 2024- St. Baldrick's Awards $573K to 3 Early-Career Pediatric OncologistsMarch 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
